A Mayo Clinic 13-year investigation of the syndrome of rapid onset ESRD among renal transplant recipients: An analysis of the implications of renal allograft biopsy results
Hemodialysis International Nov 03, 2017
Onuigbo MA, et al. - This study was undertaken to assess the impact of syndrome of rapid onset end stage renal disease (SORO-ESRD) on renal allograft survival. Findings reported a significant contribution of SORO-ESRD to late renal allograft loss and return to hemodialysis with 100% initial dialysis catheter rate. Notably, researchers discovered potentially preventable causes of AKI leading to SORO-ESRD. These findings would help reduce late renal allograft loss and the need for re-transplantation.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries